Physician

Sattar Gojraty, M.D.

According to 2025 Medicare claims, Sattar Gojraty, M.D. (NPI: 1891957445) practices cardiology in the Port St. Lucie, FL market, with the plurality of this provider's patient population coming from Martin, FL. This provider's primary affiliated billing organization is STUART CARDIOLOGY GROUP LLC (NPI: 1871603332; TIN: 650701827) and primary practice location at 34996-3329. Gojraty is affiliated with the Cleveland Clinic Florida Integrated Health (ACO ID: A3588), participating under the MSSP model.

Gojraty's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 4,950 traditional Medicare patients, billed 14,357 HCPCS/CPT codes, and received $724,840 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 8,727 prescription claims across 1,313 beneficiaries totaling $1,663,744 in drug costs, led by Eliquis (Apixaban). 2020 DME data shows 22 claims. Open Payments data shows 8 records totaling $148. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $352,233 to $724,840. Similarly, Part D prescription costs have risen steadily, from $95,660 to $1,663,744. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $2,295 to $22,033.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,064	7,573	$352,233
2016	1,981	7,279	$379,321
2017	2,229	8,681	$446,310
2018	2,566	12,183	$569,206
2019	2,985	14,889	$597,186
2020	1,670	10,467	$458,701
2021	2,181	13,335	$626,356
2022	2,175	12,727	$597,693
2023	2,862	12,548	$594,836
2024	4,950	14,357	$724,840

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	224	1,087	$95,660
2016	334	1,836	$190,028
2017	487	2,875	$302,741
2018	837	4,529	$570,898
2019	930	6,533	$903,334
2020	947	6,917	$1,057,766
2021	1,044	7,493	$1,215,764
2022	1,050	7,577	$1,332,910
2023	1,112	7,897	$1,457,040
2024	1,313	8,727	$1,663,744

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$1,702
2016	N/R	12	$1,026
2017	N/R	12	$668
2018	N/R	N/R	N/R
2019	N/R	12	$25,005
2020	N/R	22	$21,451
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	869	875	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,570	2,769	$96
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	282	487	$64
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	439	470	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	2,320	2,708	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	821	51,984	$988,215
Xarelto	Rivaroxaban	217	14,199	$252,713
Repatha Sureclick	Evolocumab	142	6,892	$130,368
Entresto	Sacubitril/Valsartan	35	2,672	$59,924
Multaq	Dronedarone Hcl	37	1,410	$35,816

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$148	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sattar Gojraty, M.D.?

Tedicare shows public-source Medicare data for Sattar Gojraty, M.D. (NPI 1891957445), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sattar Gojraty, M.D. have ACO affiliation data?

Sattar Gojraty, M.D. is shown with ACO affiliation data for Cleveland Clinic Florida Integrated Health (MSSP, ACO ID A3588).

What billing organization is linked to Sattar Gojraty, M.D.?

Sattar Gojraty, M.D. is linked to STUART CARDIOLOGY GROUP LLC (billing NPI 1871603332) in the available physician profile data.

Does Sattar Gojraty, M.D. have Open Payments data?

Sattar Gojraty, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.